Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley; Boni E. Elewski; Mark Lebwohl; Kristian Reich; Christopher Em Griffiths; Kim Papp; L. Puig; Hidemi Nakagawa; Lynda Spelman; Bárður Sigurgeirsson; Enrique Rivas; Tsen‐Fang Tsai; Norman Wasel; Stephen K. Tyring; Thomas Salko; Isabelle Hampele; Marianne Notter; Alexander Karpov; Silvia Helou; C. Papavassilis

doi:10.1056/nejmoa1314258

Abstract

1 min read

Secukinumab was effective for psoriasis in two randomized trials, validating interleukin-17A as a therapeutic target. (Funded by Novartis Pharmaceuticals; ERASURE and FIXTURE ClinicalTrials.gov numbers, NCT01365455 and NCT01358578, respectively.).

Related publications

Article2019

Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE)

Richard B. Warren, Johnathan Barker, A.Y. Finlay, A. David Burden, Brian Kirby, Y. Armendáriz, R Williams, C. Hatchard, Swarna Khare, Christopher Em Griffiths

Article2017

Inhibition of IL‐17A by secukinumab shows no evidence of increased <i>Mycobacterium tuberculosis</i> infections

Michael Kammüller, Tsen‐Fang Tsai, Christopher Em Griffiths, Nidhi Kapoor, Pappachan E. Kolattukudy, Dominique Brees, Salah‐Dine Chibout, Jorge Safi, Todd Fox

Article2016

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials

Watcharee Rungapiromnan, Zenas Z N Yiu, Richard B. Warren, Christopher Em Griffiths, Darren M. Ashcroft

Article2025

Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis

Mark Lebwohl, Melinda Gooderham, Richard B. Warren, Diamant Thaçi, Peter Foley, Alice B. Gottlieb, Tiago Torres, Zoran Popmihajlov, Ying-Ming Jou, Misti Linaberry, Carolin Daamen, Christopher Em Griffiths

Article2020

Clinical efficacy and safety of secukinumab in patients with psoriasis and comorbidities: pooled analysis of 4 phase 3 clinical trials

Alice B. Gottlieb, Jashin J. Wu, Christopher Em Griffiths, Kwaku Marfo, Elisa Muscianisi, Xiangyi Meng, Jennifer Frueh, Mark Lebwohl